EP 1560595 A2 20050810 - FULLY HUMAN ANTIBODY FAB FRAGMENTS WITH HUMAN INTERFERON-GAMMA NEUTRALIZING ACTIVITY
Title (en)
FULLY HUMAN ANTIBODY FAB FRAGMENTS WITH HUMAN INTERFERON-GAMMA NEUTRALIZING ACTIVITY
Title (de)
HUMANES GAMMA-INTERFERON NEUTRALISIERENDE FAB-FRAGMENTE AUS VOLLHUMANEM ANTIKÖRPER
Title (fr)
FRAGMENTS FAB D'ANTICORPS ENTIEREMENT HUMAINS AYANT UNE ACTIVITE DE NEUTRALISATION DE L'INTERFERON-GAMMA HUMAIN
Publication
Application
Priority
US 0233556 W 20021017
Abstract (en)
[origin: CA2502668A1] Selective binding agents of interferon-gamma (IFN.UPSILON.) are provided by the invention. More particularly, the invention provides for antibodies and antigen binding domains which selectively bind to IFN.UPSILON. and may be us ed to prevent or treat conditions relating to autoimmune and inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus and multiple sclerosis. Nucleic acid molecules encoding said antibodies and antigen binding domains, and expression vectors and host cells for the production of same are also provided.
IPC 1-7
IPC 8 full level
A61K 39/395 (2006.01); C07K 14/57 (2006.01); C07K 16/24 (2006.01)
CPC (source: EP)
C07K 16/249 (2013.01); C07K 2317/21 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
DOCDB simple family (publication)
AU 2002347978 A1 20040615; AU 2002347978 B2 20091008; CA 2502668 A1 20040603; CA 2502668 C 20130730; EP 1560595 A2 20050810; EP 1560595 A4 20051228; JP 2006502739 A 20060126; MX PA05003949 A 20050617
DOCDB simple family (application)
AU 2002347978 A 20021017; CA 2502668 A 20021017; EP 02784189 A 20021017; JP 2004553382 A 20021017; MX PA05003949 A 20021017